Cwm LLC Purchases 17,980 Shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Cwm LLC lifted its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 63.8% during the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 46,161 shares of the pharmacy operator’s stock after purchasing an additional 17,980 shares during the quarter. Cwm LLC’s holdings in Walgreens Boots Alliance were worth $414,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. Brookstone Capital Management grew its position in Walgreens Boots Alliance by 134.2% in the third quarter. Brookstone Capital Management now owns 37,588 shares of the pharmacy operator’s stock worth $337,000 after acquiring an additional 21,541 shares in the last quarter. Czech National Bank grew its position in Walgreens Boots Alliance by 7.0% in the third quarter. Czech National Bank now owns 145,962 shares of the pharmacy operator’s stock worth $1,308,000 after acquiring an additional 9,512 shares in the last quarter. Central Pacific Bank Trust Division grew its position in Walgreens Boots Alliance by 77.8% in the third quarter. Central Pacific Bank Trust Division now owns 8,000 shares of the pharmacy operator’s stock worth $72,000 after acquiring an additional 3,500 shares in the last quarter. Massmutual Trust Co. FSB ADV grew its position in Walgreens Boots Alliance by 96.8% in the third quarter. Massmutual Trust Co. FSB ADV now owns 5,527 shares of the pharmacy operator’s stock worth $50,000 after acquiring an additional 2,719 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new position in Walgreens Boots Alliance in the second quarter worth about $958,000. 58.59% of the stock is owned by institutional investors.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ:WBA opened at $10.79 on Monday. The company has a market capitalization of $9.33 billion, a price-to-earnings ratio of -1.08, a price-to-earnings-growth ratio of 1.37 and a beta of 0.70. Walgreens Boots Alliance, Inc. has a 52 week low of $8.22 and a 52 week high of $27.05. The company has a quick ratio of 0.31, a current ratio of 0.68 and a debt-to-equity ratio of 0.67. The firm has a 50 day moving average of $9.41 and a 200 day moving average of $13.06.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.36 by $0.03. The business had revenue of $37.50 billion for the quarter, compared to the consensus estimate of $35.75 billion. Walgreens Boots Alliance had a positive return on equity of 14.23% and a negative net margin of 5.85%. The business’s quarterly revenue was up 5.9% on a year-over-year basis. During the same period in the prior year, the firm posted $0.67 earnings per share. On average, sell-side analysts predict that Walgreens Boots Alliance, Inc. will post 1.57 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently commented on WBA. Bank of America dropped their price target on Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. Truist Financial dropped their price target on Walgreens Boots Alliance from $13.00 to $10.00 and set a “hold” rating for the company in a research report on Monday, October 7th. Evercore ISI boosted their target price on Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a research report on Wednesday, October 16th. TD Cowen dropped their target price on Walgreens Boots Alliance from $22.00 to $16.00 and set a “buy” rating for the company in a research report on Thursday, September 12th. Finally, Morgan Stanley dropped their target price on Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating for the company in a research report on Friday, October 11th. Four equities research analysts have rated the stock with a sell rating, eight have given a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, Walgreens Boots Alliance has an average rating of “Hold” and an average target price of $13.38.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.